Skip to main content
All lobbying filings

CENCORA, INC.

Lobbying for CENCORA, INC.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $510,000.00 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 10
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • S 2426
    Equitable Community Access to Pharmacist Services Act
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • HR 4132
    Prescription Information Modernization Act of 2025
  • S 2027
    Prescription Information Modernization Act of 2025
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S 3822
    Break Up Big Medicine Act
  • HR 363
    Territorial Economic Recovery Act
  • HR 3042
    MMEDS Act of 2025
  • HR 2213
    Medical Supply Chain Resiliency Act
 Lobbying activity 5
Medicare/Medicaid

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act  (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule Distributor bona fide service fees

Pharmacy

Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act  (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement

Health Issues

Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)

Taxation/Internal Revenue Code

Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)

Trade (domestic/foreign)

Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem